Objectives {#sec1}
==========

Appropriate assessment of the severity of limb ischaemia and the effectiveness of revascularisation is necessary for management of patients with peripheral arterial disease (PAD).[@bib1]

Several studies have shown that the pathophysiology of PAD, especially the subgroup of patients who develop critical limb ischaemia (CLI) affects multiple microvascular functions through a complex process.[@bib2] Thus, a new method of assessing the microvascular function may help augment the information provided by standard tests. Previous studies have shown the usefulness of microcirculatory evaluations during the return to baseline temperature after local heating in the diagnosis of severe limb ischaemia.[@bib3], [@bib4] To the present authors' knowledge, however, only one method based on laser speckle contrast imaging has been reported, and the correlation between blood flow parameters and the existing method has not been clarified.[@bib3]

The present study investigated skin microcirculatory responses to a thermal load test using an experimental setup composed of a heating probe and laser Doppler flowmetry (LDF) before and after revascularisation in patients with various degrees of PAD, including patients with clinical signs of CLI. To evaluate the feasibility of the test, several parameters were compared that were gleaned from the microcirculatory fluctuations with transcutaneous oxygen tension (tcPO~2~), a conventional clinical parameter.

Materials and methods {#sec2}
=====================

From November 2016 to April 2017, 58 PAD patients, including 27 with clinical signs of CLI required hospitalisation. They all underwent skin blood flow measurement of the dorsal foot after local heating \[local heating test (LHT)\]. All patients who were clinically diagnosed with CLI had at least one tcPO~2~ value (measured in the foot) of \<30 mmHg and/or an absolute ankle pressure of \<50 mmHg. Patients with collagen vascular disease, inflammatory disease, Raynaud\'s phenomenon, an axillary temperature of \>37.0°C and patients undergoing conservative treatment were excluded. The LHT was performed before and after revascularisation in a total of 39 limbs in 34 PAD patients, including 21 limbs in 17 CLI patients ([Fig. 1](#fig1){ref-type="fig"}).Figure 1Flow chart of the study cohort. PAD = peripheral arterial disease; CLI = critical limb ischaemia; EVT = endovascular treatment.Figure 1

This study was approved by the ethics committee of Tokyo Medical and Dental University Hospital. Written informed consent was obtained from all patients.

The LHTs were performed in the morning (7:00-8:00 a.m.) in a 20--23°C room. Patients were not allowed to smoke or consume caffeine for at least 24 hours before each test. Prior to testing, patients rested in the supine position for 15 minutes. Local heating was performed using an electric moxibustion instrument (Shouki E09--04, Zen Iryoki Co., Ltd., Fukuoka, Japan). The skin heat probe was set to 48°C. After 15 minutes of local heating, the heating probe was removed, and the skin blood flow in the heated area was immediately measured by LDF (Omegaflo-lab, Omegawave Inc., Tokyo, Japan). The LDF values were recorded for 15 minutes ([Fig. 2](#fig2){ref-type="fig"}A). Pre-intervention measurements were performed on the morning of the day before revascularisation, and post-intervention measurements were performed within 14 days of revascularisation.Figure 2(A) Photographs of the local heating test (LHT). Local heating was achieved with an electric moxibustion instrument (left). After 15 min of local heating, the heating probe was removed, and the measurement of skin blood perfusion in the heated area was immediately initiated using a laser Doppler flowmetry (right). (B) Typical blood flow fluctuations during the LHT. The LHT parameters were defined graphically. T~inc~ = time from the onset of the increasing phase (T~o~) to the inflection point that marked the peak perfusion value (T~p~), also known as the increasing phase time. PV~o~ = perfusion value at the onset of the increasing phase. PV~p~ = perfusion value at the peak of the increasing phase. PΔ = PV~p~ - PV~o~. S~in~ = the slope of the perfusion value distribution in the increasing phase. S~de~ = the slope of the perfusion value distribution in the first 5 min after the peak.Figure 2

The ankle brachial pressure index (ABI) was measured before and after revascularisation using an ultrasound Doppler technique. In patients with CLI, the tcPO~2~ values were also measured using a TINA TCM400 (Radiometer Medical, Copenhagen, Denmark) device according to the manufacturer\'s instructions. One of the tcPO~2~ measurements on the dorsal side of the foot was taken at the same site as the LDF measurements.

LDF data analyses {#sec2.1}
-----------------

The initial response during the return to baseline temperature after local heating was a decrease in blood perfusion. However, within the first 1--2 minutes, the perfusion values began to increase. After 2--5 minutes of increasing, the perfusion value reached the next inflection point that marked the peak, which was followed by another decrease ([Fig. 2](#fig2){ref-type="fig"}B). To assess the LHT, the following five parameters were analysed: increasing phase time (T~inc~), perfusion value change (PΔ), ratio of the perfusion value at the peak of the increasing phase (PV~p~) to the perfusion value at the onset of the increasing phase (PV~o~), increasing slope (S~in~), and decreasing slope (S~de~).The slope was obtained as the linear regression of the processed perfusion values. These parameters can be seen graphically in [Fig. 2](#fig2){ref-type="fig"}B.

Statistical analyses {#sec2.2}
--------------------

Continuous variables are expressed as median and 25th and 75th percentiles. The Mann--Whitney *U* test was used to compare differences between the pre- and post-intervention data. Spearman\'s correlation was used to examine the relationship between the two values. All statistical analyses were performed using BellCurve for Excel (Social Survey Research Information Co., Ltd. Tokyo, Japan).

Results {#sec3}
=======

A total of 39 limbs in 34 PAD patients (male, *n* = 29; female, *n* = 5; median age, 72 years; range 66.5--79 years) were analysed. The patient characteristics are shown in [Table 1](#tbl1){ref-type="table"}.Table 1Patient characteristics and risk factors of the study population.Table 1OverallCritical limb ischaemia (CLI)Claudication*n* (limbs)34 (39)17 (21)17 (18)Male (female)29 (5)13 (4)16 (1)Age72 (66.5--79)78 (69--81)71 (65--75)Hypertension (%)29 (85%)13 (74%)16 (94%)Diabetes (%)18 (53%)11 (64%)7 (41%)Haemodialysis (%)10 (29%)7 (41%)3 (18%)Current smoker (%)8 (23%)4 (23%)4 (23%)[^1]

Distribution of disease severity in the limbs with PAD, stratified according to the Rutherford classification, was as follows: category 1 (*n* = 2), category 2 (*n* = 13), category 3 (*n* = 3), category 4 (*n* = 9), category 5 (*n* = 11), and category 6 (*n* = 1). Bypass operations were performed for six CLI patients (eight limbs). Six bypass operations were performed for CLI patients: two aortobifemoral bypass operations for long aorto-iliac occlusion (four limbs) and four bypasses to the arteries below the popliteal trifurcation. Twelve revascularisation procedures for CLI patients were endovascular. The target lesions of the endovascular procedures were femoropopliteal lesions in six limbs and infrapopliteal tibioperoneal lesions in six limbs. Femopopliteal artery thrombectomy was performed in one case. All of the revascularisation procedures performed in the treatment of patients with claudication were endovascular procedures. The target lesions were iliac lesions in five limbs, femoropopliteal lesions in 12 limbs, and both iliac and femoropopliteal lesions in one limb.

The pre-operative ABI could not be measured in 12 of 21 limbs with CLI because of incompressible arteries in seven limbs, an undetectable or weak Doppler signal in four limbs, and the presence of an ankle wound in one limb. The pre-interventional median ABI was 0.44 (0.32--0.48) in the nine patients with CLI in whom ABI could be determined and 0.71 (0.58--0.85) in patients with claudication. The pre-interventional LHT parameters of the patients with CLI and those with claudication are shown in [Table 2](#tbl2){ref-type="table"}. Significant differences were observed in the T~inc~, PΔ, S~in~, and S~de~ values of the two groups. The pre- and post-intervention ABI values, the number of patent runoff vessels, tcPO~2~ values, and LHT parameters are shown in [Table 3](#tbl3){ref-type="table"}, [Table 4](#tbl4){ref-type="table"}. In the patients with CLI, the PΔ, S~in~, and S~de~ significantly increased after revascularisation. In patients with claudication, the ABI significantly increased after revascularisation; however, the LHT parameters measured before and after revascularisation did not differ significantly.Table 2Pre-interventional local heating test (LHT) parameters.Table 2Critical limb ischaemia (CLI)Claudication*p*Increasing phase time (T~inc~), s181 (153--255)155 (143--168).04Perfusion value change (PΔ), perfusion units, PU1.5 (0.9--2.7)3.40 (2.50--4.95).003Perfusion value at the peak of the increasing phase (PV~p~)/Perfusion value at the onset of the increasing phase (PV~o~)1.81 (1.26--1.93)1.85 (1.57--2.46).06Increasing slope (S~in~), PU/min0.35 (0.17--0.7)1.07 (0.43--1.66).001Decreasing slope (S~de~), PU/min0.22 (0.01--0.41)0.43 (0.33--0.81).006[^2]Table 3Ankle brachial pressure index (ABI) values, number of patent runoff vessels, transcutaneous oxygen tension (tcPO~2~) values, and local heating test (LHT) parameters pre- and post-intervention in critical limb ischaemia (CLI) patients.Table 3Pre-interventionPost-intervention*p*ABI0.44 (0.32--0.48)0.93 (0.83--1)\<.001Number of patent runoff vessels (0/1/2/3)7/10/1/30/11/6/4.010tcPO~2~, mmHg13 (6--25)37 (30--48)\<.001Increasing phase time (T~inc~), s181 (153--255)194 (160--232).950Perfusion value change (PΔ), perfusion units (PU)1.5 (0.9--2.7)3.8 (2.7--5.0)\<.001Perfusion value at the peak of the increasing phase (PV~p~)/Perfusion value at the onset of the increasing phase (PV~o~)1.81 (1.26--1.93)1.48 (1.29--1.72).529Increasing slope (S~in~), PU/min0.35 (0.17--0.7)1.03 (0.4--1.57).014Decreasing slope (S~de~), PU/min0.22 (0.01--0.41)0.64 (0.31--0.91).001[^3]Table 4Ankle brachial pressure index (ABI) values, number of patent runoff vessels, and local heating test (LHT) parameters pre- and post-intervention in patients with claudication.Table 4Pre-interventionPost-intervention*p*ABI0.71 (0.58--0.85)0.95 (0.87--1.03)\<.001Number of patent runoff vessels (0/1/2/3)0/4/8/60/4/8/61.000Increasing phase time (T~inc~), s155 (143--168)155 (141--179).874Perfusion value change (PΔ), perfusion units (PU)3.40 (2.50--4.95)3.45 (2.28--4.55).924Perfusion value at the peak of the increasing phase (PV~p~)/Perfusion value at the onset of the increasing phase (PV~o~)1.85 (1.57--2.46)1.73 (1.51--2.69).924Increasing slope (S~in~), PU/min1.07 (0.43--1.66)1.21 (0.86--1.67).601Decreasing slope (S~de~), PU/min0.43 (0.33--0.81)0.58 (0.42--0.78).517[^4]

The correlation between the tcPO~2~ values and LHT parameters is shown in [Table 5](#tbl5){ref-type="table"}. S~de~ showed the most statistically significant correlation with the tcPO~2~ value (*ρ* = .759, *p* \< .001). [Table 6](#tbl6){ref-type="table"} shows the number of patients that clinically benefited from each of the investigations for assessment of revascularisation.Table 5Correlation between the parameters of the local heating test and the transcutaneous oxygen tension (tcPO~2~) values in critical limb ischaemia (CLI) patients.Table 5ρ (Spearman)*p*Increasing phase time (T~inc~)-.362.019Perfusion value change (PΔ).628\<.001Perfusion value at the peak of the increasing phase (PV~p~)/Perfusion value at the onset of the increasing phase (PV~o~)-.288.065Increasing slope (S~in~).561\<.001Decreasing slope (S~de~).759\<.001[^5]Table 6Number of patients who benefited clinically from each of the investigations for assessment of revascularisation.Table 6Ankle brachial pressure index (ABI)Transcutaneous oxygen tension (tcPO~2~)Local heating test (LHT)Claudication (*n* = 17)15--7Critical limb ischaemia (CLI) (*n* = 17)71515[^6]

Discussion {#sec4}
==========

This study investigated fluctuations in the skin blood flow of PAD patients during the return to baseline temperature after local heating using an LDF device. The fluctuations observed are presumed to be a form of cold induced vasodilation (CIVD)[@bib5] induced by relative cooling after local heating. CIVD is a paradoxical increase in skin blood flow following initial vasoconstriction during local cold exposure that has been suggested to have a cryoprotective function.

Preliminary results showed that the increase in skin blood flow was attenuated in patients with clinically diagnosed CLI compared with those with claudication and that the attenuated microcirculatory response in patients with CLI improved after revascularisation.

To know where to look and quantitatively assess the LHT, several parameters were defined. Analysis of the results showed that the severity of ischaemia was represented by parameters related to both a transient increase and the degree of decrease in blood flow after the peak. In the present study, S~de~ was found to have the most statistically significant correlation with tcPO~2~, indicating that the secondary vasoconstriction observed several minutes after local heating is attenuated and thereby reflects the severity of limb ischaemia. Although the data were corrected using a separate device, the diagnostic value of this parameter in predicting severe ischaemia has been reported in previous studies.[@bib3], [@bib4] These results may support the applicability of the thermal load test in assessing the severity of limb ischaemia and skin microcirculatory recovery in CLI patients.

At the same time, the skin microcirculatory reactivity to the thermal load test was mostly maintained and remained unchanged following revascularisation in the diseased limbs of patients with claudication. One possible explanation for this observation is that most patients with claudication in this study had mild to moderate and stable disease; however, the thermal load test does not appear to be suitable for quantitatively assessing PAD patients with mild ischaemia.

Several potential mechanisms may underlie the changes in the blood flow fluctuations observed in this study. For example, arterioles in CLI patients are reported to be almost maximally dilated and relatively insensitive to vasodilator stimuli.[@bib6] Impaired blood flow enhancement in patients with low tcPO~2~ might mirror a low vasodilatory capacity secondary to a vasodilatory status.

In this study, the ABI could not be determined in 57% of the patients with CLI. Thus, thermal load testing may be valuable for assessing the severity of limb ischaemia in CLI patients with unreliable ABI results. Because of differences in the measuring principles used, the present method may be less markedly affected by tissue conditions, such as oedema, which leads to falsely low tcPO~2~ values. In this series, the LHT appeared to be a more useful and effective modality than tcPO~2~ in patients with CLI with post-operative limb oedema.

The present objective was not to exhaustively test the device; the aim was to assess the feasibility of thermal load testing. To establish the testing technique, it will be necessary to use a generally available heating technique. For example, an experimental setup with an infrared lamp and a laser Doppler imager[@bib7] can be adopted as a non-contact method. The results of the present study do, however, provide a basis for further discussion.

Conclusions {#sec5}
===========

The present study demonstrated the feasibility of an LDF based setup for assessing the skin blood flow via a thermal load test. Thermal load testing can be used to evaluate the severity of ischaemia in patients with PAD but needs further clinical research to confirm its value.
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[^1]: CLI = critical limb ischaemia.

[^2]: CLI = critical limb ischaemia; LHT = local heating test; PΔ = perfusion value change; PU = perfusion units; PV~o~ = perfusion value at the onset of the increasing phase; PV~p~ = perfusion value at the peak of the increasing phase; S~de~ = decreasing slope; S~in~ = increasing slope; T~inc~ = increasing phase time.

[^3]: ABI = ankle brachial pressure index; CLI = critical limb ischaemia; LHT = local heating test; PΔ = perfusion value change; PU = perfusion units; PV~o~ = perfusion value at the onset of the increasing phase; PV~p~ = perfusion value at the peak of the increasing phase; S~de~ = decreasing slope; S~in~ = increasing slope; tcPO~2~ = transcutaneous oxygen tension; T~inc~ = increasing phase time.

[^4]: ABI = ankle brachial pressure index; LHT = local heating test; PΔ = perfusion value change; PU = perfusion units; PV~o~ = perfusion value at the onset of the increasing phase; PV~p~ = perfusion value at the peak of the increasing phase; S~de~ = decreasing slope; S~in~ = increasing slope ; T~inc~ = increasing phase time.

[^5]: CLI = critical limb ischaemia; PΔ = perfusion value change; PU = perfusion units; PV~o~ = perfusion value at the onset of the increasing phase; PV~p~ = perfusion value at the peak of the increasing phase; S~de~ = decreasing slope; S~in~ = increasing slope; tcPO~2~ = transcutaneous oxygen tension; T~inc~ = increasing phase time.

[^6]: ABI = ankle brachial pressure index; CLI = critical limb ischaemia; LHT = local heating test; tcPO~2~ = transcutaneous oxygen tension.
